Excess Body Weight and Cancer-Related Fatigue, Systemic Inflammation, and Serum Lipids in Breast Cancer Survivors

References

• Peoples AR, Roscoe JA, Block RC, Heckler CE, Ryan JL, Mustian KM, Janelsins MC, Peppone LJ, Moore DF, Coles C, et al. Nausea and disturbed sleep as predictors of cancer-related fatigue in breast cancer patients: a multicenter NCORP study. Support Care Cancer. 2017;25(4):1271–8. doi:10.1007/s00520-016-3520-8
   PubMed Web of Science ®Google Scholar
• Lin P-J, Kleckner IR, Loh KP, Inglis JE, Peppone LJ, Janelsins MC, Kamen CS, Heckler CE, Culakova E, Pigeon WR, et al. Influence of yoga on cancer-related fatigue and on mediational relationships between changes in sleep and cancer-related fatigue: a nationwide, multicenter randomized controlled trial of yoga in cancer survivors. Integr Cancer Ther. 2019;18:153473541985513. doi:10.1177/1534735419855134
   Web of Science ®Google Scholar
• Mustian KM, Lin P, Loh KP, Kleckner IR. Fatigue. In: Handbook of Cancer Survivorship (2nd ed.). Cham, Switzerland: Springer; 2018. pp. 129–44.
   Google Scholar
• Palesh OG, Mustian KM, Peppone LJ, Janelsins M, Sprod LK, Kesler S, Innominato PF, Roth T, Manber R, Heckler C, et al. Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program. Sleep Med. 2012;13(9):1184–90. doi:10.1016/j.sleep.2012.06.001
   PubMed Web of Science ®Google Scholar
• Mustian KM, Roscoe JA, Palesh OG, Sprod LK, Heckler CE, Peppone LJ, Usuki KY, Ling MN, Brasacchio RA, Morrow GR, et al. Polarity Therapy for cancer-related fatigue in patients with breast cancer receiving radiation therapy: a randomized controlled pilot study. Integr Cancer Ther. 2011;10(1):27–37. doi:10.1177/1534735410397044
   PubMed Web of Science ®Google Scholar
• Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, Schnipper HH, Lacchetti C, Ligibel JA, Lyman GH, American Society of Clinical Oncology, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol. 2014;32(17):1840–50. doi:10.1200/JCO.2013.53.4495
   PubMed Web of Science ®Google Scholar
• Mortimer JE, Waliany S, Dieli-Conwright CM, Patel SK, Hurria A, Chao J, Tiep B, Behrendt CE. Objective physical and mental markers of self-reported fatigue in women undergoing (neo)adjuvant chemotherapy for early-stage breast cancer. Cancer. 2017;123(10):1810–6. doi:10.1002/cncr.30426
   PubMed Web of Science ®Google Scholar
• Zick SM, Colacino J, Cornellier M, Khabir T, Surnow K, Djuric Z. Fatigue reduction diet in breast cancer survivors: a pilot randomized clinical trial. Breast Cancer Res Treat. 2017;161(2):299–310. doi:10.1007/s10549-016-4070-y
   PubMed Web of Science ®Google Scholar
• Tabrizi FM, Alizadeh S. Cancer related fatigue in breast cancer survivors: in correlation to demographic factors. Maedica (Buchar). 2017;12:106–11.
   PubMedGoogle Scholar
• Sheng JY, Sharma D, Jerome G, Santa-Maria CA. Obese breast cancer patients and survivors: management considerations. Oncology (Williston Park). 2018;32(8):410–7.
   PubMed Web of Science ®Google Scholar
• Schmitz KH, Neuhouser ML, Agurs-Collins T, Zanetti KA, Cadmus-Bertram L, Dean LT, Drake BF. Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Cancer Inst. 2013;105(18):1344–54. doi:10.1093/jnci/djt223
   PubMedGoogle Scholar
• Inglis JE, Janelsins MC, Culakova E, Mustian KM, Lin P-J, Kleckner IR, Peppone LJ. Longitudinal assessment of the impact of higher body mass index on cancer-related fatigue in patients with breast cancer receiving chemotherapy. Support Care Cancer. 2020;28(3):1411–8. doi:10.1007/s00520-019-04953-4
   PubMed Web of Science ®Google Scholar
• Kumar NB, Fink A, Levis S, Xu P, Tamura R, Krischer J. Thyroid function in the etiology of fatigue in breast cancer. Oncotarget. 2018;9(39):25723–37. doi:10.18632/oncotarget.25438
   PubMedGoogle Scholar
• Inglis JE, Lin PJ, Kerns SL, Kleckner IR, Kleckner AS, et al. Nutritional interventions for treating cancer-related fatigue: a qualitative review. Nutr Cancer. 2019;71:1–20. doi:10.1080/01635581.2018.1513046
   PubMed Web of Science ®Google Scholar
• McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534–40. doi:10.1016/j.ctrv.2012.08.003
   PubMed Web of Science ®Google Scholar
• Lippitz BE. Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol. 2013;14(6):e218–e228. doi:10.1016/S1470-2045(12)70582-X
   PubMed Web of Science ®Google Scholar
• Lippitz BE, Harris RA. Cytokine patterns in cancer patients: a review of the correlation between interleukin 6 and prognosis. Oncoimmunology. 2016;5(5):e1093722. doi:10.1080/2162402X.2015.1093722
   PubMed Web of Science ®Google Scholar
• Xiao C, Miller AH, Felger J, Mister D, Liu T, Torres MA. Depressive symptoms and inflammation are independent risk factors of fatigue in breast cancer survivors. Psychol Med. 2017;47(10):1733–43. doi:10.1017/S0033291717000150
   PubMed Web of Science ®Google Scholar
• Lacourt TE, Heijnen CJ. Mechanisms of neurotoxic symptoms as a result of breast cancer and its treatment: considerations on the contribution of stress, inflammation, and cellular bioenergetics. Curr Breast Cancer Rep. 2017;9(2):70–81. doi:10.1007/s12609-017-0245-8
   PubMed Web of Science ®Google Scholar
• Yang S, Chu S, Gao Y, Ai Q, Liu Y, Li X, Chen N. A narrative review of cancer-related fatigue (CRF) and its possible pathogenesis. Cells. 2019;8(7):738. doi:10.3390/cells8070738
   PubMed Web of Science ®Google Scholar
• Kvehaugen AS, Aasbrenn M, Farup PG. Anti-Saccharomyces cerevisiae antibodies (ASCA) are associated with body fat mass and systemic inflammation, but not with dietary yeast consumption: a cross-sectional study. BMC Obes. 2017;4(1):28. doi:10.1186/s40608-017-0164-2
   PubMedGoogle Scholar
• Lee BC, Lee J. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta. 2014;1842(3):446–62. doi:10.1016/j.bbadis.2013.05.017
   PubMed Web of Science ®Google Scholar
• Fuggetta MP, Zonfrillo M, Villiva C, Bonmassar E, Ravagnan G. Inflammatory microenvironment and adipogenic differentiation in obesity: the inhibitory effect of theobromine in a model of human obesity in vitro. Mediators Inflamm. 2019;2019:1515621. doi:10.1155/2019/1515621
   PubMed Web of Science ®Google Scholar
• Ellulu MS, Patimah I, Khaza'ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851–63. doi:10.5114/aoms.2016.58928
   PubMed Web of Science ®Google Scholar
• Wu JM, Yang HT, Ho TW, Shun SC, Lin MT. Association between interleukin-6 levels and perioperative fatigue in gastric adenocarcinoma patients. J Clin Med. 2019;8:543. doi:10.3390/jcm8040543.
   PubMed Web of Science ®Google Scholar
• Miller WM, Nori-Janosz KE, Lillystone M, Yanez J, McCullough PA. Obesity and lipids. Curr Cardiol Rep. 2005;7(6):465–70. doi:10.1007/s11886-005-0065-8
   PubMedGoogle Scholar
• Boden G. Obesity and free fatty acids. Endocrinol Metab Clin North Am. 2008;37(3):635–46. doi:10.1016/j.ecl.2008.06.007
   PubMed Web of Science ®Google Scholar
• Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184–223. doi:10.3390/ijms15046184
   PubMed Web of Science ®Google Scholar
• Cantarero-Villanueva I, Galiano-Castillo N, Fernández-Lao C, Diaz-Rodríguez L, Fernández-Pérez AM, Sánchez MJ, Arroyo-Morales M. The influence of body mass index on survival in breast cancer patients. Clin Breast Cancer. 2015;15(2):e117–23–e123. doi:10.1016/j.clbc.2014.11.006
   PubMed Web of Science ®Google Scholar
• Gastaldelli A, Gaggini M, DeFronzo RA. Role of adipose tissue insulin resistance in the natural history of type 2 diabetes: results from the San Antonio metabolism study. Diabetes. 2017;66(4):815–22. doi:10.2337/db16-1167
   PubMed Web of Science ®Google Scholar
• Suzuki R, Tamura Y. Aging and homeostasis. Aging of skeletal muscle. Clin Calcium. 2017;27(7):925–32.
   PubMedGoogle Scholar
• Bradshaw PT, Cespedes Feliciano EM, Prado CM, Alexeeff S, Albers KB, Chen WY, Caan BJ. Adipose tissue distribution and survival among women with nonmetastatic breast cancer. Obesity (Silver Spring). 2019;27(6):997–1004. doi:10.1002/oby.22458
   PubMed Web of Science ®Google Scholar
• Ayoub NM, Yaghan RJ, Abdo NM, Matalka II, Akhu-Zaheya LM, Al-Mohtaseb AH. Impact of obesity on clinicopathologic characteristics and disease prognosis in pre- and postmenopausal breast cancer patients: a retrospective institutional study. J Obes. 2019;2019:1–11. doi:10.1155/2019/3820759
   Web of Science ®Google Scholar
• Azrad M, Blair CK, Rock CL, Sedjo RL, Wolin KY, Demark-Wahnefried W. Adult weight gain accelerates the onset of breast cancer. Breast Cancer Res Treat. 2019;176(3):649–56. doi:10.1007/s10549-019-05268-y
   PubMed Web of Science ®Google Scholar
• Uhley VE, Jen K-LC. Nutrition and weight management. In: Handbook of Cancer Survivorship. (2nd ed.). Cham, Swizerland: Springer; 2018. pp. 309–28.
   Google Scholar
• Gandhi A, Copson E, Eccles D, Durcan L, Howell A, Morris J, Howell S, McDiarmid S, Sellers K, Gareth Evans D, et al. Predictors of weight gain in a cohort of premenopausal early breast cancer patients receiving chemotherapy. Breast. 2019;45:1–6. doi:10.1016/j.breast.2019.02.006
   PubMed Web of Science ®Google Scholar
• Alacacioglu A, Kebapcilar L, Gokgoz Z, Oztekin O, Bozkaya G, Tarhan O, Somali I, Yuksel A, Sop G, Sari I, et al. Leptin, insulin and body composition changes during adjuvant taxane based chemotherapy in patients with breast cancer, preliminary study. Indian J Cancer. 2016;53(1):39–42. doi:10.4103/0019-509X.180836
   PubMed Web of Science ®Google Scholar
• Peppone LJ, Inglis JE, Mustian KM, Heckler CE, Padula GDA, et al. Multicenter randomized controlled trial of omega-3 fatty acids versus omega-6 fatty acids for the control of cancer-related fatigue among breast cancer survivors. JNCI Cancer Spectr. 2019;3:pkz005. doi:10.1093/jncics/pkz005
   PubMed Web of Science ®Google Scholar
• Khatri D, Jaiswal A, Das KK, Pandey S, Bhaisora K, Kumar R. Health-related quality of life after surgery in supratentorial gliomas. Neurol India. 2019;67(2):467–75. doi:10.4103/0028-3886.257998
   PubMed Web of Science ®Google Scholar
• Quyen TC, Angkatavanich J, Thuan TV, Xuan VV, Tuyen LD, et al. Nutrition assessment and its relationship with performance and Glasgow prognostic scores in Vietnamese patients with esophageal cancer. Asia Pac J Clin Nutr. 2017;26:49–58. doi:10.6133/apjcn.122015.02.
   PubMed Web of Science ®Google Scholar
• Khalid MA, Achakzai IK, Ahmed Khan S, Majid Z, Hanif FM, Iqbal J, Laeeq SM, Luck NH. The use of Karnofsky Performance Status (KPS) as a predictor of 3 month post discharge mortality in cirrhotic patients. Gastroenterol Hepatol Bed Bench. 2018;11(4):301–5.
   PubMedGoogle Scholar
• Tandon P, Reddy KR, O'Leary JG, Garcia-Tsao G, Abraldes JG, Wong F, Biggins SW, Maliakkal B, Fallon MB, Subramanian RM, North American Consortium for the Study of End-Stage Liver Disease, et al. A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis. Hepatology. 2017;65(1):217–24. doi:10.1002/hep.28900
   PubMed Web of Science ®Google Scholar
• Jean-Pierre P, Figueroa-Moseley CD, Kohli S, Fiscella K, Palesh OG, Morrow GR. Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist. 2007;12 Suppl 1:11–21. doi:10.1634/theoncologist.12-S1-11
   PubMed Web of Science ®Google Scholar
• Asvat Y, Malcarne VL, Sadler GR, Jacobsen PB. Validity of the multidimensional fatigue symptom inventory-short form in an African-American community-based sample. Ethn Health. 2014;19(6):631–44. doi:10.1080/13557858.2014.885933
   PubMed Web of Science ®Google Scholar
• Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999;85(5):1186–96. doi:10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N
   PubMed Web of Science ®Google Scholar
• Stein KD, Jacobsen PB, Blanchard CM, Thors C. Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage. 2004;27(1):14–23. doi:10.1016/j.jpainsymman.2003.06.003
   PubMed Web of Science ®Google Scholar
• Jones D, Zhao F, Fisch MJ, Wagner LI, Patrick-Miller LJ, Cleeland CS, Mendoza TR. The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group. Clin Genitourin Cancer. 2014;12(1):41–9. doi:10.1016/j.clgc.2013.07.003
   PubMed Web of Science ®Google Scholar
• Whitehead L. The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures. J Pain Symptom Manage. 2009;37(1):107–28. doi:10.1016/j.jpainsymman.2007.08.019
   PubMed Web of Science ®Google Scholar
• Mendoza TR, Williams LA, Keating KN, Siegel J, Elbi C, Nowak AK, Hassan R, Cuffel B, Cleeland CS. Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM). J Patient Rep Outcomes. 2019;3(1):34. doi:10.1186/s41687-019-0122-5
   PubMedGoogle Scholar
• Lagerstedt SA, Hinrichs DR, Batt SM, Magera MJ, Rinaldo P, McConnell JP. Quantitative determination of plasma c8-c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Mol Genet Metab. 2001;73(1):38–45. doi:10.1006/mgme.2001.3170
   PubMed Web of Science ®Google Scholar
• Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82. doi:10.1037//0022-3514.51.6.1173
   PubMed Web of Science ®Google Scholar
• Chen HL, Liu K, You QS. Self-efficacy, cancer-related fatigue, and quality of life in patients with resected lung cancer. Eur J Cancer Care. 2018;27(6):e12934. doi:10.1111/ecc.12934
   PubMed Web of Science ®Google Scholar
• Chan A, Yo TE, Wang XJ, Ng T, Chae J-W, Yeo HL, Shwe M, Gan YX. Minimal clinically important difference of the multidimensional fatigue symptom inventory-short form (MFSI-SF) for fatigue worsening in Asian breast cancer patients. J Pain Symptom Manage. 2018;55(3):992–7.e2. doi:10.1016/j.jpainsymman.2017.10.014
   PubMed Web of Science ®Google Scholar
• Donovan KA, Stein KD, Lee M, Leach CR, Ilozumba O, Jacobsen PB. Systematic review of the multidimensional fatigue symptom inventory-short form. Support Care Cancer. 2015;23(1):191–212. doi:10.1007/s00520-014-2389-7
   PubMed Web of Science ®Google Scholar
• van Vulpen JK, Schmidt ME, Velthuis MJ, Wiskemann J, Schneeweiss A, Vermeulen RCH, Habermann N, Ulrich CM, Peeters PHM, van der Wall E, et al. Effects of physical exercise on markers of inflammation in breast cancer patients during adjuvant chemotherapy. Breast Cancer Res Treat. 2018;168(2):421–31. doi:10.1007/s10549-017-4608-7
   PubMed Web of Science ®Google Scholar
• Khosravi M, Taghvaye Masoumi H, Gholami K, Vaezi M, Hadjibabaei M, Ghavamzadeh A. The relationship between fatigue and cytokine levels in patients with acute myeloid leukemia. Int J Hematol Oncol Stem Cell Res. 2018;12(4):318–21.
   PubMedGoogle Scholar
• Kühl T, Behrens S, Jung AY, Obi N, Thöne K, Schmidt ME, Becher H, Chang-Claude J. Validation of inflammatory genetic variants associated with long-term cancer related fatigue in a large breast cancer cohort. Brain Behav Immun. 2018;73:252–60. doi:10.1016/j.bbi.2018.05.009
   PubMed Web of Science ®Google Scholar
• De Lorenzo A, Gratteri S, Gualtieri P, Cammarano A, Bertucci P, Di Renzo L. Why primary obesity is a disease?. J Transl Med. 2019;17(1):169. doi:10.1186/s12967-019-1919-y
   PubMed Web of Science ®Google Scholar
• Font-Burgada J, Sun B, Karin M. Obesity and cancer: the oil that feeds the flame. Cell Metab. 2016;23(1):48–62. doi:10.1016/j.cmet.2015.12.015
   PubMed Web of Science ®Google Scholar
• Feng R, Luo C, Li C, Du S, Okekunle AP, Li Y, Chen Y, Zi T, Niu Y. Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case-control study. Lipids Health Dis. 2017;16(1):165. doi:10.1186/s12944-017-0551-1
   PubMed Web of Science ®Google Scholar
• Fernandez-Navarro T, Diaz I, Gutierrez-Diaz I, Rodriguez-Carrio J, Suarez A, et al. Exploring the interactions between serum free fatty acids and fecal microbiota in obesity through a machine learning algorithm. Food Res Int. 2019;121:533–41. doi:10.1016/j.foodres.2018.12.009.
   PubMed Web of Science ®Google Scholar
• Yammine S, Naja F, Tamim H, Nasrallah M, Biessy C, Aglago E, Matta M, Romieu I, Gunter M, Nasreddine L, et al. Association between serum phospholipid fatty acid levels and adiposity among lebanese adults: a cross-sectional study. Nutrients. 2018;10(10):1371. doi:10.3390/nu10101371
   PubMed Web of Science ®Google Scholar
• Kaska L, Mika A, Stepnowski P, Proczko M, Ratnicki-Sklucki K, Sledzinski T, Goyke E, Swierczynski J. The relationship between specific Fatty acids of serum lipids and serum high sensitivity C- reactive protein levels in morbidly obese women. Cell Physiol Biochem. 2014;34(4):1101–8. doi:10.1159/000366324
   PubMedGoogle Scholar
• Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56(8):365–79. doi:10.1016/s0753-3322(02)00253-6
   PubMed Web of Science ®Google Scholar
• Simopoulos AP. An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 2016;8(3):128. doi:10.3390/nu8030128
   PubMed Web of Science ®Google Scholar
• Eyob T, Ng T, Chan R, Chan A. Impact of chemotherapy on cancer-related fatigue and cytokines in 1312 patients: a systematic review of quantitative studies. Curr Opin Support Palliat Care. 2016;10(2):165–79. doi:10.1097/SPC.0000000000000205
   PubMed Web of Science ®Google Scholar
• Sha F, Zhuang S, Zhou L, Zhang L, Yang Y, Zhang S, Jiang Y, Qiu G, Chen C, Zheng J, et al. Biomarkers for cancer-related fatigue and adverse reactions to chemotherapy in lung cancer patients. Mol Clin Oncol. 2015;3(1):163–6. doi:10.3892/mco.2014.439
   PubMed Web of Science ®Google Scholar
• Zhang S, Zeng D, Peng Y, Yang Y, Zhuang X, Li Z, Wang M, Chen L, Zhang H. Cancer-related fatigue and chemotherapy-associated adverse effects: correlation with TNF-α, IL-1 and 17-hydroxycorticosteroids. Future Oncol. 2014;10(9):1619–26. doi:10.2217/fon.14.15
   PubMed Web of Science ®Google Scholar